Hemorrhoids Treatment Market Size, Share, Growth, and Industry Analysis, By Types (Drugs, Non-Surgical Procedures, Surgical Procedures, ), By Applications (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, ) , and Regional Insights and Forecast to 2035

Hemorrhoids Treatment Market Size

The Global Hemorrhoids Treatment Market size was valued at USD 649.08 Million in 2025 and is projected to reach USD 685.94 Million in 2026, growing further to USD 724.91 Million in 2027 and reaching USD 1127.78 Million by 2035, exhibiting a CAGR of 5.68% during the forecast period [2026-2035]. Around 62% of patients actively seek early hemorrhoids treatment, while nearly 55% prefer non-invasive options. About 48% of demand comes from OTC products, and close to 36% of procedures involve minimally invasive techniques, showing steady market expansion.

The US Hemorrhoids Treatment Market shows strong growth driven by awareness and healthcare access. Nearly 64% of adults report symptoms related to hemorrhoids, while around 58% prefer pharmacy-based treatments. About 52% of patients opt for non-surgical procedures, and nearly 45% rely on topical medications. Digital consultations account for close to 40% of patient engagement, improving diagnosis rates. In addition, about 50% of patients seek early-stage treatment, which supports continuous demand growth across treatment types.

Key Findings

• Market Size: $ 649.08 Million (2025) $ 685.94 Million (2026) $ 1127.78 Million (2035) with 5.68 % steady growth across the period.
• Growth Drivers: 68% linked to lifestyle habits, 57% digestive issues, 50% early treatment adoption, 42% awareness increase, 46% OTC usage rise.
• Trends: 55% prefer OTC care, 48% choose non-invasive methods, 40% herbal demand, 36% laser adoption, 52% online search behavior.
• Key Players: Bayer AG, Pfizer Inc, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, Medtronic & more.
• Regional Insights: North America 34%, Europe 27%, Asia-Pacific 29%, Middle East & Africa 10% share with rising awareness and treatment access.
• Challenges: 52% recurrence cases, 46% low awareness, 39% home remedies use, 37% surgery fear, 33% cost concerns impact treatment adoption.
• Industry Impact: 58% improved patient access, 48% innovation growth, 45% digital health adoption, 36% faster recovery solutions, 50% treatment efficiency rise.
• Recent Developments: 36% laser usage growth, 44% new OTC launches, 40% telehealth rise, 39% herbal products expansion, 30% device upgrades.

The hemorrhoids treatment market is evolving with strong focus on patient comfort and accessibility. Around 60% of patients now seek early diagnosis, while nearly 53% prefer treatments that offer quick pain relief. Non-surgical procedures are gaining attention, with about 47% of healthcare providers recommending them. Digital health platforms are influencing nearly 38% of treatment decisions, improving awareness. In addition, about 41% of patients prefer private and home-based care solutions, showing a shift toward convenient treatment options across the market.

Hemorrhoids Treatment Market Trends

The hemorrhoids treatment market is showing strong growth trends due to rising awareness, lifestyle changes, and increasing preference for non-invasive care. Around 60% of adults experience hemorrhoids at some stage, which is driving steady demand for effective hemorrhoids treatment options. Nearly 55% of patients now prefer over-the-counter products such as creams, ointments, and suppositories, highlighting a shift toward self-care and early treatment. In addition, about 48% of healthcare providers recommend minimally invasive procedures, showing a growing acceptance of advanced hemorrhoids treatment methods.

Digital health awareness has also influenced the hemorrhoids treatment market, with nearly 52% of patients searching online for treatment options before consulting a doctor. Sedentary lifestyles contribute significantly, with close to 65% of cases linked to low physical activity and poor diet habits. Fiber-based therapies are gaining traction, accounting for nearly 45% of initial treatment plans. Furthermore, laser and infrared coagulation procedures have seen adoption rates increase by over 35%, indicating a clear trend toward faster recovery solutions. Hospital-based treatments still hold around 50% share, but home-based care solutions are expanding rapidly, driven by convenience and privacy concerns.

Another key trend in the hemorrhoids treatment market is the rising demand for herbal and natural products, with nearly 40% of consumers showing preference for plant-based remedies. Additionally, around 58% of patients seek treatments that reduce pain quickly, pushing innovation in topical formulations. These trends reflect a growing focus on patient comfort, accessibility, and faster relief, making the hemorrhoids treatment market more competitive and innovation-driven.

Hemorrhoids Treatment Market Dynamics

OPPORTUNITY

"Growth in non-invasive hemorrhoids treatment solutions"

The hemorrhoids treatment market presents strong opportunities through the expansion of non-invasive procedures. Nearly 62% of patients prefer treatments that do not require surgery, creating high demand for laser therapy and infrared coagulation. Around 47% of clinics have adopted minimally invasive tools, improving treatment accessibility. Additionally, about 53% of patients report faster recovery with these methods, increasing adoption rates. Telemedicine is also supporting growth, with nearly 38% of consultations happening remotely, allowing early diagnosis and treatment planning.

DRIVERS

"Rising demand for effective hemorrhoids treatment due to lifestyle disorders"

The increasing prevalence of sedentary lifestyles and poor dietary habits is a major driver in the hemorrhoids treatment market. Around 68% of cases are linked to low fiber intake and prolonged sitting. Nearly 57% of urban populations report digestive issues, increasing the need for hemorrhoids treatment. Awareness campaigns have improved diagnosis rates by about 42%, encouraging early intervention. Additionally, around 50% of patients actively seek medical advice instead of ignoring symptoms, which is boosting treatment adoption across hospitals and home care settings.

RESTRAINTS

"Limited awareness in rural and underdeveloped regions"

Despite growth, the hemorrhoids treatment market faces challenges due to limited awareness in certain areas. Around 46% of people in rural regions delay treatment due to lack of knowledge about symptoms. Nearly 39% rely on home remedies instead of medical care, which slows market expansion. Access to healthcare facilities is restricted for about 41% of the population in remote areas. Social stigma also plays a role, with approximately 35% of patients avoiding consultation due to embarrassment, reducing early diagnosis and treatment rates.

CHALLENGE

"High recurrence rates and treatment hesitation"

One of the major challenges in the hemorrhoids treatment market is the high recurrence rate of the condition. Around 52% of patients experience recurring symptoms even after treatment, leading to hesitation in seeking repeated care. Nearly 44% of patients discontinue treatment midway due to slow results or discomfort. Additionally, about 37% of individuals fear surgical procedures, which limits the adoption of advanced treatment methods. Cost concerns also affect around 33% of patients, especially when multiple treatment sessions are required, creating barriers to consistent care.

Segmentation Analysis

The hemorrhoids treatment market is segmented based on type and application, showing a clear shift in patient preference and treatment adoption. The global hemorrhoids treatment market size was valued at USD 649.08 Million in 2025 and is projected to reach USD 685.94 Million in 2026 and USD 1127.78 Million by 2035, driven by steady demand across all segments. Around 54% of patients rely on drug-based hemorrhoids treatment, while nearly 28% opt for non-surgical procedures due to faster recovery. Surgical procedures account for close to 18% usage, mainly for severe cases. On the application side, retail pharmacies contribute about 46% of total demand, followed by hospital pharmacies at 34%, while online pharmacies are growing with nearly 20% share. These segments reflect the increasing accessibility and patient awareness in the hemorrhoids treatment market.

By Type

Drugs

Drug-based hemorrhoids treatment remains widely used due to ease of access and affordability. Nearly 55% of patients prefer creams, ointments, and oral medications for early-stage hemorrhoids. Around 48% of cases are managed successfully with drug therapy alone. Topical treatments account for about 60% of drug usage due to quick relief from pain and itching. Fiber supplements are used by nearly 42% of patients as part of initial care routines, showing strong demand in this segment.

Drugs segment Market Size, revenue in 2025 Share and CAGR for Type 1. Drugs held the largest share in the hemorrhoids treatment market, accounting for USD 649.08 Million in 2025, representing 54% of the total market. This segment is expected to grow at a CAGR of 5.68% from 2025 to 2035, driven by high patient preference and easy availability.

Non-Surgical Procedures

Non-surgical hemorrhoids treatment is gaining strong traction due to minimal discomfort and quick recovery time. Nearly 45% of healthcare providers recommend procedures like rubber band ligation and infrared coagulation. Around 38% of patients prefer these options to avoid surgery. These treatments show success rates of over 70%, making them a preferred choice for moderate conditions. Adoption of laser-based procedures has increased by nearly 36%, highlighting growing interest in advanced care.

Non-Surgical Procedures Market Size, revenue in 2025 Share and CAGR for Type 2. This segment accounted for USD 649.08 Million in 2025, representing 28% of the total market. It is expected to grow at a CAGR of 5.68% from 2025 to 2035, supported by rising demand for minimally invasive treatments.

Surgical Procedures

Surgical procedures are used in severe hemorrhoids cases where other treatments are not effective. Around 22% of patients eventually require surgical intervention. Hemorrhoidectomy and stapled procedures account for nearly 65% of surgical treatments. Despite higher recovery time, about 58% of patients report long-term relief after surgery. Hospital-based procedures dominate this segment, with close to 72% of surgeries performed in clinical settings.

Surgical Procedures Market Size, revenue in 2025 Share and CAGR for Type 3. This segment accounted for USD 649.08 Million in 2025, representing 18% of the total market. It is expected to grow at a CAGR of 5.68% from 2025 to 2035, driven by demand for permanent solutions in advanced cases.

By Application

Retail Pharmacies

Retail pharmacies play a major role in the hemorrhoids treatment market due to easy access and wide availability of products. Nearly 60% of patients purchase over-the-counter medications from retail stores. Around 52% of mild cases are treated through pharmacy-recommended solutions. Consumer preference for quick relief drives nearly 48% of repeat purchases in this segment.

Retail Pharmacies Market Size, revenue in 2025 Share and CAGR for Application 1. This segment held USD 649.08 Million in 2025, representing 46% of the total market. It is expected to grow at a CAGR of 5.68% from 2025 to 2035 due to high consumer dependence on OTC products.

Hospital Pharmacies

Hospital pharmacies contribute significantly, especially for prescribed medications and post-surgical care. Nearly 40% of patients rely on hospital pharmacies for advanced hemorrhoids treatment. Around 35% of prescriptions are fulfilled through hospitals, ensuring proper medical guidance. This segment supports nearly 50% of surgical and non-surgical procedure patients.

Hospital Pharmacies Market Size, revenue in 2025 Share and CAGR for Application 2. This segment accounted for USD 649.08 Million in 2025, representing 34% of the total market. It is expected to grow at a CAGR of 5.68% from 2025 to 2035, supported by clinical treatment demand.

Online Pharmacies

Online pharmacies are rapidly growing in the hemorrhoids treatment market due to convenience and privacy. Nearly 44% of consumers prefer online platforms for discreet purchases. Around 39% of repeat buyers use online channels for refilling medications. Discounts and home delivery services drive nearly 41% of customer preference in this segment.

Online Pharmacies Market Size, revenue in 2025 Share and CAGR for Application 3. This segment accounted for USD 649.08 Million in 2025, representing 20% of the total market. It is expected to grow at a CAGR of 5.68% from 2025 to 2035, driven by digital adoption and convenience.

Hemorrhoids Treatment Market Regional Outlook

The hemorrhoids treatment market shows varied growth across regions, supported by healthcare access and awareness levels. The global hemorrhoids treatment market size reached USD 649.08 Million in 2025 and is projected to touch USD 685.94 Million in 2026 and USD 1127.78 Million by 2035. North America holds around 34% share, Europe accounts for 27%, Asia-Pacific represents 29%, and Middle East & Africa contributes 10%. Increasing patient awareness, improved healthcare systems, and rising cases of digestive disorders are driving growth across all regions.

North America

North America dominates the hemorrhoids treatment market due to high awareness and advanced healthcare systems. Nearly 62% of adults report hemorrhoid-related symptoms, increasing treatment demand. Around 58% of patients prefer non-invasive treatments, while 46% rely on OTC medications. Hospital visits for hemorrhoids treatment have increased by nearly 35%. Digital consultations account for about 40% of patient interactions, improving early diagnosis rates.

North America Market Size, Share and CAGR for region. North America accounted for USD 233.22 Million in 2026, representing 34% of the total market. This growth is driven by high awareness, strong healthcare access, and adoption of advanced treatments.

Europe

Europe shows steady growth in the hemorrhoids treatment market due to rising aging population and lifestyle-related issues. Around 55% of adults face digestive disorders linked to hemorrhoids. Nearly 50% of patients prefer pharmacy-based treatments, while 38% opt for minimally invasive procedures. Preventive care awareness has improved by about 42%, increasing early treatment adoption.

Europe Market Size, Share and CAGR for region. Europe accounted for USD 185.20 Million in 2026, representing 27% of the total market. Growth is supported by strong healthcare systems and patient awareness.

Asia-Pacific

Asia-Pacific is witnessing rapid growth in the hemorrhoids treatment market due to large population and changing diets. Nearly 60% of cases are linked to low fiber intake and sedentary habits. Around 48% of patients rely on retail pharmacies, while 36% use home remedies initially. Awareness campaigns have improved diagnosis rates by about 33%.

Asia-Pacific Market Size, Share and CAGR for region. Asia-Pacific accounted for USD 198.92 Million in 2026, representing 29% of the total market. Growth is driven by increasing awareness and expanding healthcare access.

Middle East & Africa

The Middle East & Africa region shows gradual growth in the hemorrhoids treatment market. Around 45% of patients delay treatment due to limited awareness. Nearly 38% depend on traditional remedies, while 32% access modern healthcare facilities. Urban areas show higher treatment adoption, with about 41% of patients seeking medical care.

Middle East & Africa Market Size, Share and CAGR for region. This region accounted for USD 68.59 Million in 2026, representing 10% of the total market. Growth is supported by improving healthcare infrastructure and awareness.

List of Key Hemorrhoids Treatment Market Companies Profiled

Investment Analysis and Opportunities in Hemorrhoids Treatment Market

The hemorrhoids treatment market is attracting strong investment due to rising patient demand and innovation in treatment methods. Nearly 52% of healthcare investors are focusing on minimally invasive technologies. Around 47% of funding is directed toward product development in topical treatments and laser procedures. Startups contribute nearly 35% of innovation in non-surgical solutions. Digital health platforms account for about 38% of new investments, supporting remote diagnosis and treatment. Increasing demand for herbal products, preferred by 40% of users, is also creating new investment opportunities. Expansion in emerging markets is supported by nearly 45% growth in healthcare infrastructure investments.

New Products Development

New product development in the hemorrhoids treatment market is focused on faster relief and improved patient comfort. Nearly 50% of new products are topical formulations designed for instant pain relief. Around 42% of companies are developing plant-based treatments to meet rising demand for natural solutions. Advanced laser devices account for about 33% of innovations in procedural treatment. User-friendly packaging and dosage forms have improved patient compliance by nearly 37%. Additionally, nearly 45% of new launches focus on reducing recurrence rates, showing strong emphasis on long-term effectiveness and convenience.

Recent Developments

• Advanced laser therapy adoption: Nearly 36% of healthcare providers have integrated laser-based hemorrhoids treatment, improving patient recovery rates and reducing procedure time by around 28%, enhancing overall treatment efficiency.
• Expansion of OTC product lines: Around 44% of companies introduced new creams and ointments, improving symptom relief rates by nearly 32% and increasing consumer preference for self-treatment options.
• Growth in telehealth services: Digital consultations increased by about 40%, enabling early diagnosis and boosting treatment adoption rates by nearly 27% among patients seeking remote care.
• Introduction of herbal formulations: Nearly 39% of new products are plant-based, meeting consumer demand for natural solutions and improving adoption rates by around 25%.
• Improved surgical devices: About 30% of manufacturers upgraded surgical tools, enhancing precision and reducing recovery time by nearly 22%, supporting better patient outcomes.

Report Coverage

The hemorrhoids treatment market report provides detailed insights into key factors influencing growth, including strengths, weaknesses, opportunities, and threats. Strength analysis shows that nearly 60% of patients prefer early treatment options, supporting strong demand across segments. Around 55% of healthcare providers are adopting advanced treatment technologies, enhancing efficiency. Weakness analysis highlights that nearly 46% of patients delay treatment due to lack of awareness, while about 39% rely on home remedies, affecting market penetration.

Opportunity analysis reveals that around 62% of patients are shifting toward non-invasive treatments, creating strong growth potential. Nearly 48% of companies are focusing on product innovation to improve patient comfort. Expansion in emerging regions contributes to about 45% of new growth opportunities due to improving healthcare infrastructure. Threat analysis indicates that nearly 52% of patients face recurrence issues, impacting long-term treatment success. Additionally, about 37% of patients hesitate to undergo surgical procedures, limiting adoption of advanced solutions.

The report also covers segmentation insights, where drugs account for over 50% usage, while non-surgical procedures show increasing demand. Regional analysis highlights that North America and Asia-Pacific together contribute over 60% of total demand. Overall, the report offers a clear view of market trends, competitive landscape, and future growth opportunities supported by data-driven insights and percentage-based analysis.